StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-2.91%)

Close on Nov 17, 2026Market cap $383.64KP/E –Yield –

VivoSim Labs total assets

Total assets on the balance sheet at the end of each period.

VivoSim Labs's total assets was $3.85M at Jun 30, 2026. For fiscal 2026 it was $7.39M, down 49.6% from the year before. Over ten years it grew -19.9% a year on average. The highest annual figure on record is $69.18M in fiscal 2017.

Annual total assets

PeriodPeriod endValueChange
FY2026Mar 31, 2026$7.39M-49.6%
FY2025Mar 31, 2025$14.65M+130.7%
FY2024Mar 31, 2024$6.35M-68.7%
FY2023Mar 31, 2023$20.31M-39.0%
FY2022Mar 31, 2022$33.30M-16.6%
FY2021Mar 31, 2021$39.92M+40.4%
FY2020Mar 31, 2020$28.44M-30.0%
FY2019Mar 31, 2019$40.62M-18.5%
FY2018Mar 31, 2018$49.83M-28.0%
FY2017Mar 31, 2017$69.18M+2.4%
FY2016Mar 31, 2016$67.58M+26.3%
FY2015Mar 31, 2015$53.49M+219.4%
FY2012Dec 31, 2012$16.75M+1088.7%
FY2011Dec 31, 2011$1.41M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$3.85M-67.9%
Q4 FY2026CQ1 2026Mar 31, 2026$7.39M-49.6%
Q3 FY2026CQ4 2025Dec 31, 2025$6.96M+81.1%
Q2 FY2026CQ3 2025Sep 30, 2025$9.69M+43.4%
Q1 FY2026CQ2 2025Jun 30, 2025$11.98M+26.5%
Q4 FY2025CQ1 2025Mar 31, 2025$14.65M+130.7%
Q3 FY2025CQ4 2024Dec 31, 2024$3.84M-56.7%
Q2 FY2025CQ3 2024Sep 30, 2024$6.75M-39.5%
Q1 FY2025CQ2 2024Jun 30, 2024$9.47M-35.8%
Q4 FY2024CQ1 2024Mar 31, 2024$6.35M-68.7%
Q3 FY2024CQ4 2023Dec 31, 2023$8.88M-64.6%
Q2 FY2024CQ3 2023Sep 30, 2023$11.16M-60.0%
Q1 FY2024CQ2 2023Jun 30, 2023$14.76M-51.7%
Q4 FY2023CQ1 2023Mar 31, 2023$20.31M-39.0%
Q3 FY2023CQ4 2022Dec 31, 2022$25.08M-28.5%
Q2 FY2023CQ3 2022Sep 30, 2022$27.91M-22.2%
Q1 FY2023CQ2 2022Jun 30, 2022$30.55M-20.2%
Q4 FY2022CQ1 2022Mar 31, 2022$33.30M-16.6%
Q3 FY2022CQ4 2021Dec 31, 2021$35.10M+62.6%
Q2 FY2022CQ3 2021Sep 30, 2021$35.88M+73.8%
Q1 FY2022CQ2 2021Jun 30, 2021$38.29M+49.5%
Q4 FY2021CQ1 2021Mar 31, 2021$39.92M+40.4%
Q3 FY2021CQ4 2020Dec 31, 2020$21.58M-31.1%
Q2 FY2021CQ3 2020Sep 30, 2020$20.64M-45.3%
Q1 FY2021CQ2 2020Jun 30, 2020$25.62M-41.0%
Q4 FY2020CQ1 2020Mar 31, 2020$28.44M-30.0%
Q3 FY2020CQ4 2019Dec 31, 2019$31.31M-21.1%
Q2 FY2020CQ3 2019Sep 30, 2019$37.77M-11.4%
Q1 FY2020CQ2 2019Jun 30, 2019$43.45M-3.6%
Q4 FY2019CQ1 2019Mar 31, 2019$40.62M-18.5%
Q3 FY2019CQ4 2018Dec 31, 2018$39.69M-25.9%
Q2 FY2019CQ3 2018Sep 30, 2018$42.63M-25.1%
Q1 FY2019CQ2 2018Jun 30, 2018$45.09M-26.9%
Q4 FY2018CQ1 2018Mar 31, 2018$49.83M-28.0%
Q3 FY2018CQ4 2017Dec 31, 2017$53.55M-29.7%
Q2 FY2018CQ3 2017Sep 30, 2017$56.91M-1.1%
Q1 FY2018CQ2 2017Jun 30, 2017$61.71M–
Q4 FY2017CQ1 2017Mar 31, 2017$69.18M–
Q3 FY2017CQ4 2016Dec 31, 2016$76.13M–
Q2 FY2017CQ3 2016Sep 30, 2016$57.54M–

More VivoSim Labs figures

See a number that looks wrong?